Jessica M. Silva-Fisher, Ph.D.

Instructor
Internal Medicine
Oncology

General Program

  • 314-273-4216

  • 8069

  • Room 9940, Wohl Clinic Building

  • silvajm@wustl.edu

  • https://www.silvafisherlab.com/

  • Cancer, multiple myeloma, breast cancer, long non-coding rnas, regulatory rnas, novel therapies, metastasis,multi-omics, sequencing

  • Multi-omic characterization of regulatory RNAs in multiple myeloma and late-stage relapse breast cancer

Research Abstract:

Our Research focus is to study the basic mechanisms of regulatory RNAs including non-protein coding genes called long non-coding RNAs (lncRNAs) in multiple myeloma and late-stage relapse breast cancer to target them and use them for new cancer treatments.

We use multi-omic approaches (RNA sequencing, single-cell RNA sequencing, Chromatin immunoprecipitation (ChIP) sequencing, and RNA immunoprecipitation (RIP) sequencing, etc.) to identify de-regulated RNAs and their associated protein interactors. We then conduct in vitro molecular biology assays to determine their functions and mechanisms in the cell. This information is then used to target the RNA using novel RNA antisense oligo therapies for future use as novel therapies.

Selected Publications:

Voices on Diversity: Multiple Paths to Becoming a Scientist
Silva-Fisher J, Nervo LM, Addo T, Guerra A, Walker M, Guerrier S, McGill L, Brooks D, Joseph J, Johnson J, Ayombil F, Odinammadu K
Mol Cell 2020 Dec 3;80(5):752-757

Long Non-Coding RNA RAMS11 Promotes Metastatic Colorectal Cancer Progression
Silva-Fisher JM, Dang HX, White NM, Strand MS, Krasnick BA, Rozycki EB, Jeffers GGL, Grossman JG, Highkin MK, Tang C, Cabanski CR, Eteleeb A, Mudd J, Goedegebuure SP, Luo J, Mardis ER, Wilson RK, Ley TJ, Lockhart AC, Fields RC, Maher CA
Nat Commun 2020 May 1;11(1):2156

Pan-Cancer Transcriptome Analysis Reveals Long Noncoding RNAs With Conserved Function
Cabanski CR, White NM, Dang HX, Silva-Fisher JM, Rauck CE, Cicka D, Maher CA
RNA Biol 2015;12(6):628-42

Transcriptome Sequencing Reveals Altered Long Intergenic Non-Coding RNAs in Lung Cancer
White NM, Cabanski CR, Silva-Fisher JM, Dang HX, Govindan R, Maher CA
Genome Biol 2014 Aug 13;15(8):429

LSINCT5 Is Over Expressed in Breast and Ovarian Cancer and Affects Cellular Proliferation
Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI
RNA Biol 2011 May-Jun;8(3):496-505

Long non-coding RNAs and Cancer
Silva JM, Smith D
In: Kevin V. Morris (Ed), Long Non-coding RNAs: Regulation of Gene Expression and Drivers of Natural Selection, (Chapter 9), The Scripps Research Institute, La Jolla, California, Caister Academic Press, 2011

Identification of Long Stress-Induced Non-Coding Transcripts That Have Altered Expression in Cancer
Silva JM, Perez DS, Pritchett JR, Halling ML, Tang H, Smith DI
Genomics 2010 Jun;95(6):355-62

Akt-Induced Tamoxifen Resistance Is Associated With Altered FKHR Regulation
Silva J, Cavazos DA, Donzis E, Friedrichs WE, Marciniak R, deGraffenried LA
Cancer Invest 2007;25(7):569-73

Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity
deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA, Hidalgo M
Clin Cancer Res 2004 Dec 1;10(23):8059-67

NF-Kappa B Inhibition Markedly Enhances Sensitivity of Resistant Breast Cancer Tumor Cells to Tamoxifen
deGraffenried LA, Chandrasekar B, Friedrichs WE, Donzis E, Silva J, Hidalgo M, Freeman JW, Weiss GR
Ann Oncol 2004 Jun;15(6):885-90

Eicosapentaenoic Acid Restores Tamoxifen Sensitivity in Breast Cancer Cells With High Akt Activity
deGraffenried LA, Friedrichs WE, Fulcher L, Fernandes G, Silva JM, Peralba JM, Hidalgo M
Ann Oncol 2003 Jul;14(7):1051-6

Last Updated: 1/3/2021 3:32:18 PM

Back To Top

Follow us: